Monday, August 24, 2026

BTC $79,057 ▲ 1.70%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.220−3.17%ETH$2,473+0.42%LINK$11.57+0.25%SOL$95.88+0.48%BTC$79,057+1.70%XRP$1.48−2.83%S&P 5007,659−0.20%Nasdaq26,033−0.56%Dow53,438+0.30%RUT2,998−0.66%TNX4.70%−0.80%TYX5.23%−0.91%FVX4.40%−0.43%IRX3.70%−0.19%VIX15.77+4.23%GOLD$4,696.60+0.34%SILVER$68.61−1.33%OIL$85.18−2.16%DXY99.01+0.21%NVDA$209.42−2.47%AAPL$311.20+0.60%TSLA$350.67−3.36%META$560.17+1.87%MSFT$488.16+1.02%AMZN$262.04+1.32%GOOGL$348.68+1.12%Fear & Greed73 — GreedADA$0.220−3.17%ETH$2,473+0.42%LINK$11.57+0.25%SOL$95.88+0.48%BTC$79,057+1.70%XRP$1.48−2.83%S&P 5007,659−0.20%Nasdaq26,033−0.56%Dow53,438+0.30%RUT2,998−0.66%TNX4.70%−0.80%TYX5.23%−0.91%FVX4.40%−0.43%IRX3.70%−0.19%VIX15.77+4.23%GOLD$4,696.60+0.34%SILVER$68.61−1.33%OIL$85.18−2.16%DXY99.01+0.21%NVDA$209.42−2.47%AAPL$311.20+0.60%TSLA$350.67−3.36%META$560.17+1.87%MSFT$488.16+1.02%AMZN$262.04+1.32%GOOGL$348.68+1.12%Fear & Greed73 — Greed

Tag

Melanoma Vaccine

1 article

U.S. EquitiesYesterday

Moderna Surges 177% on Melanoma Vaccine Win; Wall Street Raises Targets

Moderna stock soared on positive Phase 3 results for its personalized melanoma vaccine with Merck, prompting Morgan Stanley to raise its price target to $89 from $39.